ACCPL
Accretion Pha.
Pharmaceuticals · ₹141 Cr market cap
A pharmaceutical manufacturer incorporated in 2012, Accretion Pharmaceuticals produces tablets, capsules, and other healthcare products for domestic and international markets. The company operates across multiple therapeutic segments, focusing on formulation development, quality manufacturing, and distribution. Its distinctive strength lies in vertically integrated operations combining research capabilities with modern production facilities and a wide distribution network across India and select overseas regions.
0
Tracked investors holding
1
Tracked moves
₹161
Share price
Latest activity
Unicorn FundNew position
Unicorn Fund bought 67,200 shares of Accretion Pharmaceuticals for ₹69 lakh at ₹102.60 apiece in a bulk deal on April 29, 2026.